Sterol Regulatory Element-binding Proteins (SREBPs): Key Regulators of Nutritional Homeostasis and Insulin Action
Open accessAbstract
sterol regulatory element-binding protein sterol regulatory element sterol regulatory element-binding protein-1c or adipocyte differentiation and determination factor-1 basic helix-loop-helix bHLH leucine zipper low density lipoprotein cAMP-response element-binding protein vitamin D receptor-interacting protein activator-recruited cofactor fatty acid synthase polyunsaturated fatty acid(s) The sterol regulatory element-binding proteins (SREBPs)1 were first identified by two groups working independently on cholesterol metabolism (1Yokoyama C. Wang X. Briggs M.R. Admon A. Wu J. Hua X. Goldstein J.L. Brown M.S. Cell. 1993; 75: 185-197Crossref Google Scholar, 2Hua X. Yokoyama C. Wu J. Briggs M.R. Brown M.S. Goldstein J.L. Wang X. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 11603-11607Crossref PubMed Scopus (522) Google Scholar) and fat cell differentiation (3Tontonoz P. Kim J.B. Graves R.A. Spiegelman B.M. Mol. Cell. Biol. 1993; 13: 4753-4759Crossref PubMed Scopus (545) Google Scholar). Subsequent studies have demonstrated there are three major SREBP isoforms encoded by two different genes (4Brown M.S. Goldstein J.L. Cell. 1997; 89: 331-340Abstract Full Text Full Text PDF PubMed Scopus (3097) Google Scholar). These unique members of the basic helix-loop-helix leucine zipper (bHLHLZ) family of transcriptional regulatory proteins can be distinguished from other family members by two characteristics. The first is they are synthesized as precursors that are threaded into membranes of the endoplasmic reticulum and nuclear envelope in a hairpin orientation such that the amino and carboxyl tails both face the cytoplasm. The amino-terminal half of the precursor is clipped out of the membrane in two steps responding to regulatory cues that signal the need for increased cellular cholesterol (5Sakai J. Duncan E.A. Rawson R.B. Hua X. Brown M.S. Goldstein J.L. Cell. 1996; 85: 1037-1046Abstract Full Text Full Text PDF PubMed Scopus (442) Google Scholar). The released amino-terminal fragment, which contains the transcriptional activation and DNA binding domains, is targeted to the nucleus where it activates expression of SREBP target genes. The second distinguishing feature of the SREBPs is that they have a unique dual DNA binding specificity, which is discussed below. Two of the three major isoforms are produced from the SREBP-1 gene, which contains two promoters (6Miserez A.R. Cao G. Probst L. Hobbs H.H. Genomics. 1997; 40: 31-40Crossref PubMed Scopus (91) Google Scholar). Transcription from each promoter produces an mRNA with a unique first exon that encodes one of the alternative amino termini referred to as 1a and 1c, respectively (Fig.1). These alternate exons are attached during mRNA splicing to a common second exon in the same reading frame, and therefore, the remaining protein coding information of both isoforms is identical. There is alternative mRNA splicing at the 3′-end as well (7Hua X. Wu J. Goldstein J.L. Brown M.S. Hobbs H.H. Genomics. 1995; 25: 667-673Crossref PubMed Scopus (253) Google Scholar), but this does not appear to be conserved in all mammalian species and its functional significance remains unclear (8Shimomura L. Shimano H. Horton J.D. Goldstein J.L. Brown M.S. J. Clin. Invest. 1997; 99: 838-845Crossref PubMed Scopus (650) Google Scholar). In contrast, mRNAs produced through alternative promoter usage at the 5′-end yield proteins with significant differences in their capacity to activate gene expression (9Shimano H. Horton J.D. Shimomura L. Hammer R.E. Brown M.S. Goldstein J.L. J. Clin. Invest. 1997; 99: 846-854Crossref PubMed Scopus (704) Google Scholar). The longer amino-terminal region in SREBP-1a contains a high percentage of acidic amino acids that make it a potent transcriptional activation domain. The SREBP-1c isoform is a much weaker activator of gene expression because it lacks 29 acidic amino acids present in 1a. Using a nuclease mapping technique to evaluate the relative levels of SREBP-1a and SREBP-1c mRNA, the ratio was shown to vary over an ∼50–100-fold range in different tissues of the body. In liver and adipocytes, 1c mRNA is 9- and 3-fold, respectively, more abundant than SREBP-1a, whereas in spleen SREBP-1a is 10 times more abundant than 1c (8Shimomura L. Shimano H. Horton J.D. Goldstein J.L. Brown M.S. J. Clin. Invest. 1997; 99: 838-845Crossref PubMed Scopus (650) Google Scholar). Whether these ratios reflect similar differences in the levels of each protein remains to be firmly established. In all cultured cell lines examined, SREBP-1a was expressed at higher levels (8Shimomura L. Shimano H. Horton J.D. Goldstein J.L. Brown M.S. J. Clin. Invest. 1997; 99: 838-845Crossref PubMed Scopus (650) Google Scholar). 1c mRNA is the predominant isoform in adult liver and adipocytes, so it is likely to be the key protein involved in SREBP-1-dependent processes in these tissues. Why different tissues express different ratios of SREBP-1a and -1c is not clear. It is possible that the more active 1
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SREBP-2 regulates the transcription of cholesterol-related genes, such as HMGCR and LDLr.
“SREBP-2 regulates the transcription of cholesterol-related genes, such as 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR), which catalyzes a rate-limiting step in cholesterol biosynthesis, and the low-density lipoprotein receptor (LDLr), which imports cholesterol from the blood (5–7).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [7]
The section “Selective Roles for Individual SREBP Isoforms in Either Cholesterol or Fatty Acid Metabolism” says SREBP-2 may preferentially activate genes involved in cholesterol homeostasis, supporting the general point. The passages do not identify HMGCR or LDLr as SREBP-2 transcriptional targets; the specific LDL-receptor expression example instead concerns SREBP-1a. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredSREBP-1c regulates the transcription of genes involved in fatty acid metabolism, such as FASN.
“SREBP-1c regulates the transcription of genes involved in fatty acid metabolism, such as fatty acid synthase (FASN) (5–7).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Nuclear protein CBP is a coactivator for the transcription factor CREB
Kwok, R. P. S., Lundblad, J. R., Chrivia, J. C., Richards, J. P., Bächinger, H. P., Brennan, R. G., Roberts, S. G. E., Green, M. R., & Goodman, R. H. (1994) · Nature · doi:10.1038/370223a0 · Cited by 1,443 · see citing works
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Hua, X., Yokoyama, C., Wu, J., Briggs, M. R., Brown, M. S., Goldstein, J. L., and Wang, X. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11603-11607
- Athanikar, J. N., and Osborne, T. F. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4935-4940
- Horton, J. D., Bashmakov, Y., Shimomura, I., and Shimano, H. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 5987-5992
- Shimomura, I., Bashmakov, Y., Shimano, H., Horton, J. D., Goldstein, J. L., and Brown, M. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12354 -12359
- Sheng, Z., Otani, H., Brown, M. S., and Goldstein, J. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 935-938
- Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., and Goldstein, J. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 13656 -13661
- Bennett, M. K., and Osborne, T. F. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 6340 -6344
- Foretz, M., Guichard, C., Ferre, P., and Foufelle, F. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12737-12742
Cited by
Sorted by citations
ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700 · see citing works
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C. M., Warrier, N. P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102281108 · Cited by 670 · see citing works
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
Oram, J. F., & Vaughan, A. M. (2006) · Circulation Research · doi:10.1161/01.res.0000250171.54048.5c · Cited by 411 · see citing works
Disorders in the initial steps of steroid hormone synthesis
Miller, W. L. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.009 · Cited by 205 · see citing works
MicroRNA 33 Regulates Glucose Metabolism
Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00016-13 · Cited by 154 · see citing works
Goedeke, L., Salerno, A., Ramírez, C. M., Guo, L., Allen, R. M., Yin, X., Langley, S. R., Esau, C., Wanschel, A., Fisher, E. A., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404046 · Cited by 145 · see citing works
Caveolae and intracellular trafficking of cholesterol
Fielding, C. J., & Fielding, P. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00140-5 · Cited by 116 · see citing works
Debeljak, N., Fink, M., & Rozman, D. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00418-6 · Cited by 103 · see citing works
Teran-Garcia, M., Adamson, A. W., Yu, G., Rufo, C., Suchankova, G., Dreesen, T. D., Tekle, M., Clarke, S. D., & Gettys, T. W. (2007) · Biochemical Journal · doi:10.1042/bj20061722 · Cited by 104 · see citing works
Sánchez, J., Palou, A., & Picó, C. (2009) · Endocrinology · doi:10.1210/en.2009-0466 · Cited by 98 · see citing works
Schmelzer, C., Kubo, H., Mori, M., Sawashita, J., Kitano, M., Hosoe, K., Boomgaarden, I., Döring, F., & Higuchi, K. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900155 · Cited by 53 · see citing works
Cholesterol: From Feeding to Gene Regulation
Martini, C., & Pallottini, V. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0049-y · Cited by 53 · see citing works
Regulation of fatty acid and cholesterol synthesis: co-operation or competition?
Gibbons, G. F. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00034-1 · Cited by 51 · see citing works
- Authors
- Osborne, T. F.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Osborne, Timothy F.
- ORCID
- Osborne, Timothy F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-10
- Volume
- 275
- Issue
- 42
- Pages
- 32379-32382
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972561828
- Cited by
- 521
- References
- 2
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 10 · 2023: 7 · 2022: 13 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 13 · 2016: 23 · 2015: 14 · 2014: 18 · 2013: 25 · 2012: 16
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (1z01hl004804-02)
- National Heart, Lung, and Blood Institute (R01HL048044, HL4804)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- SREBP, SREBP-1c, nutritional homeostasis, insulin action, adipogenesis, adipose tissue, lipid metabolism, cholesterol metabolism, endoplasmic reticulum, transcriptional regulation, bHLH transcription factors, adipose tissue fibrosis, adipose tissue regeneration, adipose tissue remodeling
- MeSH terms
- Animals, Cholesterol, DNA-Binding Proteins, Fatty Acids, Homeostasis, Humans, Insulin, Nutritional Physiological Phenomena, Transcription Factors, CCAAT-Enhancer-Binding Proteins, Sterol Regulatory Element Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review